Thinking Small has lead to the biggest breakthrough. Yesterday, Reglagene's CEO Richard Austin presented at the BIO International Convention in San Diego. Here, he discussed how Reglagene's therapy has the unique ability to cross through the blood-brain barrier and fight brain cancer. Reach out to learn more!

Thank you Angel Capital Association for selecting Reglagene as one of your Innovation Funders Showcase companies! CEO Richard Austin captivated the audience in Columbus, Ohio with a presentation on how "Thinking Small" has changed the way we think about treating brain cancer.

Thrilled to have been part of Destination Startup hosted by Venture Partners at CU Boulder! Reglagene's CEO, Richard Austin, captivated a full room at 1:00 PM MDT with an exciting presentation focused on business and scientific milestones. A big thank you to Tech Launch Arizona for the invitation and to Stephen Miller for coordinating this fantastic event!

Pitching to a full house during Reglagene's presentation at BIO CEO & Investor Conference, in Times Square, New York City!

What a week at JP Morgan Healthcare! Met amazing investors and service providers, fueling Reglagene's journey in developing innovative brain therapies.

CEO Richard Austin and Director of Operations Michael Abrahamson attended Texas Life Science Forum 2023.

Drs. Suzuki, Patrón, and Gokhale present at the AACR Special Conference on Brain Cancer in Minneapolis, MN.

Reglagene’s Richard Austin was on a panel during the AZAdvances Innovation Showcase during AZBio Week.

Richard Austin and Michael Abrahamson are joined by Board Chair Lawrence Kinet, Tripp Shannon, CFA, and Jeff Koenig at Seattle’s Keiretsu Syndication Summit & Keiretsu Family Office Forum.